Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

NCT04766086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Group B Streptococcus Infections

Interventions

BIOLOGICAL: Multivalent Group B streptococcus vaccine
BIOLOGICAL: Tetanus, diphtheria, and acellular pertussis vaccine
BIOLOGICAL: Placebo

Sponsor

Pfizer